טוען...
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
Although survival of multiple myeloma patients has at least doubled during recent years, most patients eventually relapse, and treatment at this stage may be particularly complex. At the time of relapse, the use of alternative drugs to those given upfront is current practice. However, many new optio...
שמור ב:
| הוצא לאור ב: | Drugs |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756574/ https://ncbi.nlm.nih.gov/pubmed/29188449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-017-0841-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|